Package 17856-1162-1

{"route": ["ORAL"], "spl_id": "3892f322-6fd8-1a19-e063-6394a90a70fe", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1298324"], "spl_set_id": ["308f50dd-e8d6-0264-e063-6394a90afa68"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (17856-1162-1)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "17856-1162-1", "marketing_start_date": "20250317"}], "brand_name": "Mucus Relief DM Extended Release Caplets", "product_id": "17856-1162_3892f322-6fd8-1a19-e063-6394a90a70fe", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "17856-1162", "generic_name": "Guaifenesin, Dextromethorphan HBr", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucus Relief DM Extended Release Caplets", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "30 mg/1"}, {"name": "GUAIFENESIN", "strength": "600 mg/1"}], "application_number": "ANDA209692", "marketing_category": "ANDA", "marketing_start_date": "20181213", "listing_expiration_date": "20261231"}